ID MDHC_MEDSA Reviewed; 332 AA. AC O48905; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1998, sequence version 1. DT 16-JUN-2009, entry version 69. DE RecName: Full=Malate dehydrogenase, cytoplasmic; DE EC=1.1.1.37; GN Name=CMDH; OS Medicago sativa (Alfalfa). OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta; OC Spermatophyta; Magnoliophyta; eudicotyledons; core eudicotyledons; OC rosids; eurosids I; Fabales; Fabaceae; Papilionoideae; Trifolieae; OC Medicago. OX NCBI_TaxID=3879; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=cv. Saranac; TISSUE=Root nodule; RX MEDLINE=98388648; PubMed=9721676; RX DOI=10.1046/j.1365-313X.1998.00192.x; RA Miller S.S., Driscoll B.T., Gregerson R.G., Gantt J.S., Vance C.P.; RT "Alfalfa malate dehydrogenase (MDH): molecular cloning and RT characterization of five different forms reveals a unique nodule- RT enhanced MDH."; RL Plant J. 15:173-184(1998). CC -!- CATALYTIC ACTIVITY: (S)-malate + NAD(+) = oxaloacetate + NADH. CC -!- SUBUNIT: Homodimer (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). CC -!- SIMILARITY: Belongs to the LDH/MDH superfamily. MDH type 2 family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF020272; AAB99756.1; -; mRNA. DR PIR; T09291; T09291. DR HSSP; P11708; 4MDH. DR BRENDA; 1.1.1.37; 815. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005488; F:binding; IEA:InterPro. DR GO; GO:0030060; F:L-malate dehydrogenase activity; IEA:EC. DR GO; GO:0006096; P:glycolysis; IEA:InterPro. DR GO; GO:0006108; P:malate metabolic process; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW. DR InterPro; IPR001557; L-lactate/malate_DH. DR InterPro; IPR001236; Lactate/malate_DH. DR InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C. DR InterPro; IPR001252; Malate_DH_AS. DR InterPro; IPR011274; Malate_DH_NAD-dep_euk. DR InterPro; IPR010945; Malate_DH_SF1. DR InterPro; IPR016040; NAD(P)-bd_dom. DR Gene3D; G3DSA:3.90.110.10; lact_mal_DH; 1. DR Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1. DR PANTHER; PTHR23382; MDH_SF1; 1. DR Pfam; PF02866; Ldh_1_C; 1. DR Pfam; PF00056; Ldh_1_N; 1. DR PIRSF; PIRSF000102; Lac_mal_DH; 1. DR ProDom; PD003052; Mal_dehydrog; 1. DR TIGRFAMs; TIGR01759; MalateDH-SF1; 1. DR TIGRFAMs; TIGR01758; MDH_euk_cyt; 1. DR PROSITE; PS00068; MDH; 1. PE 2: Evidence at transcript level; KW Cytoplasm; NAD; Oxidoreductase; Tricarboxylic acid cycle. FT CHAIN 1 332 Malate dehydrogenase, cytoplasmic. FT /FTId=PRO_0000113416. FT NP_BIND 12 18 NAD (By similarity). FT NP_BIND 130 132 NAD (By similarity). FT ACT_SITE 188 188 Proton acceptor (By similarity). FT BINDING 93 93 Substrate (By similarity). FT BINDING 99 99 Substrate (By similarity). FT BINDING 106 106 NAD (By similarity). FT BINDING 113 113 NAD (By similarity). FT BINDING 132 132 Substrate (By similarity). FT BINDING 163 163 Substrate (By similarity). SQ SEQUENCE 332 AA; 35547 MW; D9F38F868DE3D628 CRC64; MAKDPVRVLV TGAAGQIGYA LVPMIARGVM LGPDQPVILH MLDIAPAAES LNGVKMELVD AAFPLLKGVV ATTDVVEACT GVNIAVMVGG FPRKEGMERK DVMSKNVSIY KSQASALEKH AAANCKVLVV ANPANTNALI LKEFAPSIPE RNISCLTRLD HNRALGQISE RLNVQVSDVK NVIIWGNHSS TQYPDVNHAT VNTPAGEKPV RQLVSDDAWL NGEFISTVQQ RGAAIIKARK LSSALSAASA ACDHIRDWVL GTPQGTFVSM GVYSDGSYNV PSGLIYSFPV TCANGEWKIV QGLSIDEFSR KKLDLTAEEL TEEKNLAHSC LS //